Canary Medical Inc.

Canary Medical Inc. is a Canadian company focused on developing innovative medical devices and digital healthcare solutions that aim to enhance patient care and data management. Founded in 2014 and headquartered in Vancouver, Canada, Canary Medical Inc. specializes in advanced medical devices, particularly implantable devices with remote monitoring capabilities.

The company has raised a total of USD 10. 00 mn through various funding rounds, with the latest being a VENTURE DEBT round of USD 20. 00 mn in January 2021, involving investors such as Horizon Technology Finance Corporation and Silicon Valley Bank. The founders include Airplane Die, Bill Hunter, and David Mcmasters, who have a history of entrepreneurship in the healthcare technology sector.

Canary Medical Inc. specializes in developing advanced medical devices and associated digital healthcare solutions aimed at enhancing patient care and data management. The company's primary offerings include innovative implantable devices equipped with remote monitoring capabilities that allow for continuous collection and transmission of patient health data. These devices are designed to improve decision-making processes for healthcare providers and enhance patient engagement through real-time insights into their health status.

Canary Medical's products target a diverse clientele that includes healthcare providers, hospitals, and patients across various geographical markets, specifically in North America and Europe. The end users benefit from a streamlined approach to monitoring chronic conditions, which ultimately aims to improve health outcomes and reduce the need for frequent in-person visits. Canary Medical generates revenue through a mix of direct-to-consumer sales and business-to-business partnerships. The company structures its transactions around subscription models for ongoing monitoring services linked to its implantable devices, offering clients consistent access to data and support.

Additionally, revenue comes from partnerships with healthcare providers who integrate these devices into their patient care protocols. Specific pricing plans for these products and services are undisclosed, encompassing flagship offerings that include their proprietary implantable monitoring devices and related software solutions. This business model reflects a commitment to facilitating a modern approach to healthcare delivery, ensuring that both clinicians and patients can leverage the benefits of real-time medical data. In January 2021, Canary Medical Inc.

raised USD 20. 00 mn in VENTURE DEBT financing from new investors Horizon Technology Finance Corporation and Silicon Valley Bank. This funding aims to support the development of upcoming products and the expansion into new markets, specifically targeting additional regions in North America and Europe by the end of 2023.